Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Peripheral Arterial DiseaseChronic Limb Ischemia
Interventions
DEVICE

Pedra Tissue Perfusion Monitor

This study is a prospective single-centre, device observational study designed to enroll up to 60 evaluable subjects at 1 investigational site in the United Kingdom. Eligible subjects, who meet the requirements for one of the 3 distinct subject groups: (1) Critical Limb Ischaemia group, (2) Peripheral artery disease with superficial femoral arterial (SFA) or popliteal artery disease and (3) PAD-free group. Subjects who meet study eligibility criteria will be enrolled consecutively until the total number of subjects is enrolled per each group as outlined in the protocol. All subjects at the investigational site will be enrolled in the presence of a member of the Sponsor or selected designee in order to assist with the device operation and to verify that all protocol assessments are completed appropriately at baseline.

Trial Locations (1)

CB2 0QQ

Addenbrooke's Hospital, Department of Vascular Surgery, Cambridge

All Listed Sponsors
lead

Pedra Technology, PTE LTD

INDUSTRY

NCT03294902 - Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System | Biotech Hunter | Biotech Hunter